Stock Events

Stock Events

Karyopharm Therapeutics (25K0.STU) Q2 2026 Earnings

14MayConfirmed

Q1 2026

Q2 2026

-4.81

-3.56

-2.31

-1.06

Details

Expected EPS

-1.2149166939

Actual EPS

-1.0630519999999999

Surprise EPS

0.15

Surprise Percent

+12.5%

Description

Karyopharm Therapeutics (25K0.STU) has reported earnings of -1.0630519999999999 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.